Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer Journal of Clinicians, 71, 209–249. https://doi.org/10.3322/caac.21660.

Article  CAS  Google Scholar 

Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., & Lencioni, R., et al. (2021). Hepatocellular carcinoma. Nature Reviews Disease Primers, 7, 6. https://doi.org/10.1038/s41572-020-00240-3.

Article  PubMed  Google Scholar 

Forner, A., Reig, M., & Bruix, J. (2018). Hepatocellular carcinoma. Lancet, 391, 1301–1314. https://doi.org/10.1016/S0140-6736(18)30010-2.

Article  PubMed  Google Scholar 

Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., & Tian, Y., et al. (2024). Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. Journal of Hematology Oncology, 17, 16. https://doi.org/10.1186/s13045-024-01535-8.

Article  PubMed  PubMed Central  Google Scholar 

Hartke, J., Johnson, M., & Ghabril, M. (2017). The diagnosis and treatment of hepatocellular carcinoma. Seminars Diagnostic Pathology, 34, 153–159. https://doi.org/10.1053/j.semdp.2016.12.011.

Article  Google Scholar 

Nishida, N., & Kudo, M. (2017). Oncogenic signal and tumor microenvironment in hepatocellular carcinoma. Oncology, 93,160–164. https://doi.org/10.1159/000481246.

Article  PubMed  Google Scholar 

Gao, B., Wang, Y., & Lu, S. (2022). Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment. Functional & Integrative Genomics, 23, 6. https://doi.org/10.1007/s10142-022-00933-w.

Article  CAS  Google Scholar 

Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J. F., & de Oliveira, A. C., et al. (2008). Sorafenib in advanced hepatocellular carcinoma. New England Journal of Medicine, 359, 378–390. https://doi.org/10.1056/NEJMoa0708857.

Article  CAS  PubMed  Google Scholar 

Rimassa, L., Personeni, N., Czauderna, C., Foerster, F., & Galle, P. (2021). Systemic treatment of HCC in special populations. Journal of Hepatology, 74, 931–943. https://doi.org/10.1016/j.jhep.2020.11.026.

Article  PubMed  Google Scholar 

Jeck, W. R., & Sharpless, N. E. (2014). Detecting and characterizing circular RNAs. Nature Biotechnology, 32, 453–461. https://doi.org/10.1038/nbt.2890.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patop, I. L., Wust, S., & Kadener, S. (2019). Past, present, and future of circRNAs. EMBO Journal, 38, e100836. https://doi.org/10.15252/embj.2018100836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kristensen, L. S., Jakobsen, T., Hager, H., & Kjems, J. (2022). The emerging roles of circRNAs in cancer and oncology. Nature Review Clinical Oncology, 19, 188–206. https://doi.org/10.1038/s41571-021-00585-y.

Article  CAS  Google Scholar 

Chen, L. L. (2020). The expanding regulatory mechanisms and cellular functions of circular RNAs. Nature Reviews Molecular Cell Biology, 21, 475–490. https://doi.org/10.1038/s41580-020-0243-y.

Article  CAS  PubMed  Google Scholar 

Zhou, W. Y., Cai, Z. R., Liu, J., Wang, D. S., Ju, H. Q., & Xu, R. H. (2020). Circular RNA: metabolism, functions and interactions with proteins. Molecular Cancer, 19, 172. https://doi.org/10.1186/s12943-020-01286-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang, C., Zhuang, H., Wang, W., Wang, Q., Ma, X., Wang, B., & Zhang, Z., et al. (2024). CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell Death Disease, 15, 191. https://doi.org/10.1038/s41419-024-06570-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan, Y. R., Jiang, B. H., Feng, W. J., He, Z. L., Jiang, Y. L., Xun, Y., & Wu, X. P., et al. (2024). Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression. Aging (Albany NY), 16, 1796–1807. https://doi.org/10.18632/aging.205460.

Article  CAS  PubMed  Google Scholar 

Gao, P., Yang, Y., Li, X., Zhao, Q., Liu, Y., Dong, C., & Zhang, Y., et al. (2023). Circular RNA hsa_circ_0098181 inhibits metastasis in hepatocellular carcinoma by activating the Hippo signaling pathway via interaction with eEF2. Annals of Hepatology, 28, 101124. https://doi.org/10.1016/j.aohep.2023.101124.

Article  CAS  PubMed  Google Scholar 

Yan, L., Zheng, M., & Wang, H. (2019). Circular RNA hsa_circ_0072309 inhibits proliferation and invasion of breast cancer cells via targeting miR-492. Cancer Management and Research, 11, 1033–1041. https://doi.org/10.2147/CMAR.S186857.

Article  PubMed  PubMed Central  Google Scholar 

Guo, X., Qin, M., Hong, H., Xue, X., Fang, J., Jiang, L., Kuang, Y., et al., (2021). Circular RNA hsa_circ_0072309 inhibits the proliferation, invasion and migration of gastric cancer cells via inhibition of PI3K/AKT signaling by activating PPARgamma/PTEN signaling. Molecular Medicine Reports 23. https://doi.org/10.3892/mmr.2021.11988

Yuan, F., Sun, Q., Xu, Y., Zhang, H., Deng, G., Yang, J., & Zhang, S., et al. (2021). Hsa_circ_0072309 inhibits proliferation and invasion of glioblastoma. Pathology Research and Practice, 222, 153433. https://doi.org/10.1016/j.prp.2021.153433.

Article  CAS  PubMed  Google Scholar 

Yang, L., Tan, W., Wei, Y., Xie, Z., Li, W., Ma, X., & Wang, Q., et al. (2022). CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3beta/beta-catenin signaling pathway. Cell Death Disease, 13, 464. https://doi.org/10.1038/s41419-022-04887-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995). Interleukin-6 family of cytokines and gp130. Blood, 86, 1243–1254.

Article  CAS  PubMed  Google Scholar 

Kishimoto, T., Taga, T., & Akira, S. (1994). Cytokine signal transduction. Cell, 76, 253–262. https://doi.org/10.1016/0092-8674(94)90333-6.

Article  CAS  PubMed  Google Scholar 

Hu, H., Zhao, Q., Sang, Y., Xiao, Y., & Jiang, N. (2023). Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis. Journal of International Medical Research, 51, 3000605231182557. https://doi.org/10.1177/03000605231182557.

Article  CAS  PubMed  Google Scholar 

Zhang, F., Wang, Y., Li, H., Li, L., Yang, X., You, X., & Tang, L. (2023). Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma. Frontiers in Oncology, 13, 1118906. https://doi.org/10.3389/fonc.2023.1118906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng, L., Yan, B., Jin, G., Han, W., Wang, H., Wang, Z., & Ma, Y., et al. (2022). Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development. Journal of Molecular Histology, 53, 173–186. https://doi.org/10.1007/s10735-021-10044-8.

Article  CAS  PubMed  Google Scholar 

Liu, Q., Cao, G., Wan, Y., Xu, C., He, Y., & Li, G. (2021). Hsa_circ_0001073 targets miR-626/LIFR axis to inhibit lung cancer progression. Environmental Toxicology, 36, 1052–1060. https://doi.org/10.1002/tox.23104.

Article  CAS  PubMed  Google Scholar 

Luo, Q., Wang, C., Jin, G., Gu, D., Wang, N., Song, J., & Jin, H., et al. (2015). LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway. Carcinogenesis, 36, 1201–1212. https://doi.org/10.1093/carcin/bgv108.

Article  CAS  PubMed  Google Scho